Table 2.
Baseline CD4 counts and viral loads of study participants at ART initiation of the 701 children on ART
| Cases | Controls | |||
|---|---|---|---|---|
| |
|
Median (IQR) |
Median (IQR) |
P value* |
| Absolute CD4 count |
Overall |
241 (79–534) |
313 (127–625) |
0.035 |
| |
≤ 5 years |
542 (273 – 1214) |
728 (461 – 1129) |
0.038 |
| |
>5-10 years |
257 (133–474) |
272 (147–382) |
0.873 |
| |
>10 – 18 years |
135 (50–210) |
130 (44–262) |
0.622 |
| |
Mean (SD) |
Mean (SD) |
P value |
|
| Percentage CD4 count |
Overall |
15 (10.5) |
16 (11.0) |
0.223 |
| |
≤ 5 years |
19 (10.9) |
19 (9.5) |
0.945 |
| |
>5-10 years |
15 (8.3) |
16 (12.1) |
0.406 |
| |
>10 – 18 years |
11 (10.0) |
13 (11.0) |
0.283 |
| |
Median (IQR) |
Median (IQR) |
P value* |
|
| Viral load (x10 4) |
Overall |
12.0 (2.4 – 38.6) |
7.8 (2.3 - 35) |
0.176 |
| |
≤ 5 years |
18.8 (2.9 – 75) |
17.7 (2.5 – 52.5) |
0.283 |
| |
>5-10 years |
4.4 (1.5 – 17.4) |
6.1 (1.8 – 28.6) |
0.658 |
| >10 – 18 years | 13.1 (2.4 – 37.0) | 7.6 (2.0 – 25.5) | 0.183 | |
* P value based on Wilcoxon rank-sum test.
The baseline CD4 counts, and viral loads were.